Clinical Effect of Insulin Aspart on Pregnant Women with Gestational Dia-betes
Objective To analyze the value of treating pregnant women with gestational diabetes mellitus using men-thol insulin.Methods The clinical data of 70 pregnant women with gestational diabetes admitted to Yanzhou District People's Hospital in Jining City from December 2021 to December 2023 were retrospectively selected and divided into two groups according to treatment methods,with 35 cases in each group.The control group was treated with bio-synthetic insulin and the observation group was treated with menthol insulin.The two groups were compared in terms of blood glucose,insulin index,total cholesterol,total bilirubin,uric acid,and the incidence of adverse pregnancy out-comes.Results After treatment,glycated hemoglobin(4.69±0.79)%,fasting plasma glucose(4.66±0.61)mmol/L,and 2 h postprandial plasma glucose(7.11±1.56)mmol/L of the observation group were lower than(5.88±1.56)%,(5.79±0.85)mmol/L,and(8.44±1.85)mmol/L of the control group,and the differences were statistical significance(t=4.026,6.389,3.251,all P<0.05).Insulin index,total cholesterol,total bilirubin,and uric acid levels in the observation group were better than those in the control group,and the differences were statistically significant(all P<0.05).The inci-dence of adverse pregnancy outcomes in the observation group was lower than that in the control group,and the differ-ence was statistically significant(P<0.05).Conclusion Mentholated insulin is efficacious in the treatment of gesta-tional diabetes mellitus,improving pancreatic β-cell function and reducing the incidence of adverse pregnancy out-comes.